A hematopoietic organ-specific 49-kD nuclear antigen: predominance in immature normal and tumor granulocytes and detection in hematopoietic precursor cells.
A 49-kD protein was specifically detected in hematopoietic organs by Western blotting with a novel mouse monoclonal antibody (B92) raised against stromal cells. The protein was found in the immunizing cells using a sensitive method. However, its detection in the bone marrow by the B92 antibody seemed to stem from the abundance of p49 in immature cells of the myeloid lineage. Study of the bone marrow following in vivo irradiation or 5-fluorouracil (5-FU) treatment, in vitro culture with differentiation-inducing factors and long-term culture, and cell sorting all pointed in the same direction: the protein was found in early myeloid cells and in hematopoietic precursor cells. These results were in accordance with the specific presence of p49 in primary radiation-induced myeloid leukemia and its absence in spontaneous B lymphoma. Immunofluorescent staining using B92 antibody detected a nuclear antigen forming a dotted pattern in early myeloid cells and day 12 colony-forming units-spleen (CFU-S). Nuclear localization of p49 was further demonstrated by subcellular fractionation followed by Western blotting. We thus identified a nuclear protein that within the hematopoietic population is detected in hematopoietic precursor cells, predominates in early myeloid cells, and is reduced following differentiation. These properties imply that p49 might be involved in the regulation of hematopoietic cell growth or differentiation.
Lee
B C
BC
Department of Molecular Cell Biology, the Weizmann Institute of Science, Rehovot, Israel.
Shav-Tal
Y
Y
Peled
A
A
Gothelf
Y
Y
Jiang
W
W
Toledo
J
J
Ploemacher
R E
RE
Haran-Ghera
N
N
Zipori
D
D
D000208:Acute Disease; D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology / Q000302:isolation & purification*; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D002454:Cell Differentiation / Q000187:drug effects; D002467:Cell Nucleus / Q000276:immunology*; D002478:Cells, Cultured; D005260:Female; D005472:Fluorouracil / Q000494:pharmacology; D006098:Granulocytes / Q000187:drug effects / Q000276:immunology*; D016298:Hematopoietic Cell Growth Factors / Q000494:pharmacology; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D007942:Leukemia, Experimental / Q000276:immunology / Q000473:pathology; D007951:Leukemia, Myeloid / Q000276:immunology / Q000473:pathology; D007953:Leukemia, Radiation-Induced / Q000276:immunology / Q000473:pathology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000276:immunology / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D008970:Molecular Weight; D009687:Nuclear Proteins / Q000276:immunology / Q000302:isolation & purification*; D009928:Organ Specificity; D011833:Radiation Injuries, Experimental / Q000276:immunology / Q000473:pathology; D011994:Recombinant Proteins / Q000494:pharmacology
D000951:Antigens, Neoplasm; D016298:Hematopoietic Cell Growth Factors; D009687:Nuclear Proteins; D011994:Recombinant Proteins; D005472:Fluorouracil